Form 4 for VRCA Verrica Pharmaceuticals Inc.
Accepted 2023-08-28 00:00:00 ET · period of report 2023-08-24 · accession 0001209191-23-047518 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-28 | 2023-08-24 | VRCA | Bonaccorso Joe | Chief Commercial Off | A - Grant | $0.00 | +62.5K | 125.2K | +100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-24 | A | A | 62,500 | $0.00 | 125,238 | D | — | — | (F1) Represents vesting of shares of common stock underlying performance stock units resulting from the achievement of certain non-financial milestones. These shares have not been delivered. |